Sfoglia per RIVISTA
LANCET (LONDON, ENGLAND)
Collezione AOU Alessandria

  

Items : 3

2026
AOU Alessandria

Herhaus P; Wirths S; Meerten TV; Heß G; Jachimowicz RD; Kerkhoff A; Stilgenbauer S; Jiang L; Leppä S; da Silva MG; Shpilberg O; Vergote VKJ; Trneny M; Riise J; Mey U; Hutchings M; Walewski J; Jerkeman M; Giné E; Doorduijn J; Dreyling M; Hoster E; Ladetto M; Tix T; Unterhalt M; Schmidt C; Klapper W; Pott C; Stefani PM; et alii...

2024
AOU Alessandria

Dreyling M; Doorduijn J; Giné E; Jerkeman M; Walewski J; Hutchings M; Mey U; Riise J; Trneny M; Vergote V; Shpilberg O; Gomes da Silva M; Leppä S; Jiang L; Stilgenbauer S; Kerkhoff A; Jachimowicz RD; Celli M; Hess G; Arcaini L; Visco C; van Meerten T; Wirths S; Zinzani PL; Novak U; Herhaus P; Benedetti F; Sonnevi K; Hanoun C; et alii...

Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial. in Lancet (London, England) / Lancet. 2023 Dec 16;402(10419):2295-2306. doi: 10.1016/S0140-6736(23)01613-6. Epub 2023 Nov 3.

2023
AOU Alessandria

Chu Q; Perrone F; Greillier L; Tu W; Piccirillo MC; Grosso F; Lo Russo G; Florescu M; Mencoboni M; Morabito A; Cecere FL; Ceresoli GL; Dawe DE; Zucali PA; Pagano M; Goffin JR; Sanchez ML; Gridelli C; Zalcman G; Quantin X; Westeel V; Gargiulo P; Delfanti S; Tu D; Lee CW; Leighl N; Sederias J; Brown-Walker P; Luo Y; et alii...